RSS

Falsified Medicines Directive (FMD)

We are now six months passed the EU FMD deadline and various organisations like EMVO have begun to ask the authorities to take out sanctions against companies that don’t comply with the FMD regulations. Read more

Opinion

Six months on from the Falsified Medicines Directive (FMD) Oliver Pittock, managing director at Valley Northern discusses the status of the directive and the next steps for success. Read more

Opinion

On the back of changing regulations for pharmaceutical security in the supply chain, we speak to Carlos Ruiz Martinez, pharma operations leader at Almirall to find out how companies are coping. Read more

Opinion

European Pharmaceutical Manufacturer editor Reece Armstrong sits down with Neil Gleghorn, CEO of labelling provider Kallik, to discuss compliance challenges for manufacturers and the threat of counterfeit medicines. Read more

Opinion

FutureLink speaker and operation director at IBI Lorenzini, Luca Pezzano, discusses the benefits of aggregation and the challenges of implementing it in a post-FMD deadline environment. Read more

News

A cloud-based end-to-end warehouse compliance solution has been released to help pharma companies better comply with the EU Falsified Medicines Directive (FMD) and US Drug Supply Chain Security Act (DSCSA). Read more

News

Christian Taylor, serialisation business consultant at Zetes, provides his five-step plan to becoming FMD compliant. Read more

Opinion

Stanley Chia, senior vice president at e-invoicing supplier, Tungsten Network, details the importance of secure supply chains in the age of the counterfeit drug. Read more

Opinion 2 Comments

Ben Jones, technical manager, global serialisation services at PCI Pharma Services, discusses the complex world of serialisation and what strategies pharma companies can implement. Read more

Opinion

As we draw ever nearer to the time that compliance with the European Falsified Medicines Directive (FMD) is required, we discuss the value of serialisation beyond compliance and outsourcing with six leading solutions providers. Read more

Latest Issue

In the run up to the European Falsified Medicines Directive Markus Rosenkranz, leader Serialisation Solutions, Rockwell Automation EMEA, discusses how best to meet the interoperability challenges head on and drive return on investment. Read more

Latest Issue

In this exclusive interview, we discuss the digitalisation of the supply chain, compliance with European Falsified Medicines Directive and TraceLink’s Product Information Manager with the company’s vice president, solutions marketing, Dan Walles. Read more

Opinion

Colin Newbould, the Wasdell Group, discusses upcoming deadlines and what companies should be thinking about as the scope and requirements of track and trace legislation continue to change. Read more

Opinion

As the deadlines for the US Drug Supply Chain Security Act (DSCSA) and the Falsified Medicines Directive (FMD) near, pharma businesses should be prioritising the validation of their solutions. Here, Lauren Catalano, Sharp Services, offers guidance Read more

Opinion

In this article with EPM, Dexter Tjoa, director of Corporate Strategy, discusses why outsourcing is fast becoming the most logical choice for companies who have delayed developing appropriate solutions and what benefits an experienced CPO can bring Read more

Opinion

In this interview, we at EPM magazine speak with Staffan Widengren, director of corporate projects at Recipharm on the difficulties CDMOs are facing leading up to the European Falsified Medicines Directive (EU FMD) deadline in February 2019. Read more

Opinion

Earlier this month (9 August) we passed the six-month time point before all companies in Europe will be expected to comply with the falsified medicines directive (FMD). Read more

Opinion

A partnership has been announced between ACG Inspection (ACGI) and CertiRx (Verinetics) to further enhance traceability and authenticity solutions and strengthen their fight against falsified medicines. Read more

News

We have now passed the six month point before the Falsified Medicines Directive (FMD) comes into force. In this online exclusive, Mark Davison, senior operations director, rfxcel insists you ACT NOW! Here are six short reflections. Read more

Opinion

In this online opinion piece, Mark Davison, head of operations in the EU for rfxcel, outlines everything marketing authorisation holders (MAHs) need to know and what is needed for a seamless serialisation process Read more

Opinion 1 Comments

  • Atlantic Zeiser

    Atlantic Zeiser